0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Myasthenia Gravis Treatment Market Size, Status and Forecast 2021-2027
Published Date: February 2021
|
Report Code: QYRE-Auto-37S4165
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Myasthenia Gravis Treatment Market Size Status and Forecast 2021 2027

Global Myasthenia Gravis Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-37S4165
Report
February 2021
93 Pages
QYResearch
Region: Global, North America, Europe, Canada, France, Germany, Italy, Russia, UAE, Southeast Asia, Saudi Arabia, Turkey, South Korea,
Description
Table of Content
Tables & Figures
Myasthenia Gravis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Medication
    Surgery
Segment by Application
    Hospitals
    Clinics
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Alexion Pharmaceutical Inc.
    Grifols SA
    Avadel Pharmaceuticals plc.
    Novartis AG
    Pfizer; Inc.
    AbbVie Inc.
    F. Hoffmann-La Roche Ltd.
    GlaxoSmithKline plc
    Bausch Health Companies Inc.
    Novartis AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Treatment Market Perspective (2016-2027)
2.2 Myasthenia Gravis Treatment Growth Trends by Regions
2.2.1 Myasthenia Gravis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myasthenia Gravis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Myasthenia Gravis Treatment Industry Dynamic
2.3.1 Myasthenia Gravis Treatment Market Trends
2.3.2 Myasthenia Gravis Treatment Market Drivers
2.3.3 Myasthenia Gravis Treatment Market Challenges
2.3.4 Myasthenia Gravis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis Treatment Players by Revenue (2016-2021)
3.1.2 Global Myasthenia Gravis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Myasthenia Gravis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Treatment Revenue
3.4 Global Myasthenia Gravis Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Treatment Revenue in 2020
3.5 Myasthenia Gravis Treatment Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Treatment Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027)
5 Myasthenia Gravis Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Myasthenia Gravis Treatment Market Size (2016-2027)
6.2 North America Myasthenia Gravis Treatment Market Size by Type
6.2.1 North America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
6.2.2 North America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
6.2.3 North America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
6.3 North America Myasthenia Gravis Treatment Market Size by Application
6.3.1 North America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
6.3.2 North America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
6.3.3 North America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
6.4 North America Myasthenia Gravis Treatment Market Size by Country
6.4.1 North America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
6.4.2 North America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Myasthenia Gravis Treatment Market Size (2016-2027)
7.2 Europe Myasthenia Gravis Treatment Market Size by Type
7.2.1 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2027)
7.3 Europe Myasthenia Gravis Treatment Market Size by Application
7.3.1 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2027)
7.4 Europe Myasthenia Gravis Treatment Market Size by Country
7.4.1 Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type
8.2.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application
8.3.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region
8.4.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Treatment Market Size (2016-2027)
9.2 Latin America Myasthenia Gravis Treatment Market Size by Type
9.2.1 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
9.3 Latin America Myasthenia Gravis Treatment Market Size by Application
9.3.1 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
9.4 Latin America Myasthenia Gravis Treatment Market Size by Country
9.4.1 Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type
10.2.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application
10.3.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country
10.4.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceutical Inc.
11.1.1 Alexion Pharmaceutical Inc. Company Details
11.1.2 Alexion Pharmaceutical Inc. Business Overview
11.1.3 Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Introduction
11.1.4 Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.1.5 Alexion Pharmaceutical Inc. Recent Development
11.2 Grifols SA
11.2.1 Grifols SA Company Details
11.2.2 Grifols SA Business Overview
11.2.3 Grifols SA Myasthenia Gravis Treatment Introduction
11.2.4 Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.2.5 Grifols SA Recent Development
11.3 Avadel Pharmaceuticals plc.
11.3.1 Avadel Pharmaceuticals plc. Company Details
11.3.2 Avadel Pharmaceuticals plc. Business Overview
11.3.3 Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Introduction
11.3.4 Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.3.5 Avadel Pharmaceuticals plc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Myasthenia Gravis Treatment Introduction
11.4.4 Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer; Inc.
11.5.1 Pfizer; Inc. Company Details
11.5.2 Pfizer; Inc. Business Overview
11.5.3 Pfizer; Inc. Myasthenia Gravis Treatment Introduction
11.5.4 Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.5.5 Pfizer; Inc. Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Myasthenia Gravis Treatment Introduction
11.6.4 AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Details
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Myasthenia Gravis Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline plc Recent Development
11.9 Bausch Health Companies Inc.
11.9.1 Bausch Health Companies Inc. Company Details
11.9.2 Bausch Health Companies Inc. Business Overview
11.9.3 Bausch Health Companies Inc. Myasthenia Gravis Treatment Introduction
11.9.4 Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.9.5 Bausch Health Companies Inc. Recent Development
11.10 Shire plc.
11.10.1 Shire plc. Company Details
11.10.2 Shire plc. Business Overview
11.10.3 Shire plc. Myasthenia Gravis Treatment Introduction
11.10.4 Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.10.5 Shire plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medication
    Table 3. Key Players of Surgery
    Table 4. Global Myasthenia Gravis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Myasthenia Gravis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Myasthenia Gravis Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Myasthenia Gravis Treatment Market Share by Regions (2016-2021)
    Table 8. Global Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
    Table 10. Myasthenia Gravis Treatment Market Trends
    Table 11. Myasthenia Gravis Treatment Market Drivers
    Table 12. Myasthenia Gravis Treatment Market Challenges
    Table 13. Myasthenia Gravis Treatment Market Restraints
    Table 14. Global Myasthenia Gravis Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Myasthenia Gravis Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020)
    Table 17. Ranking of Global Top Myasthenia Gravis Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Myasthenia Gravis Treatment Product Solution and Service
    Table 21. Date of Enter into Myasthenia Gravis Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Myasthenia Gravis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Alexion Pharmaceutical Inc. Company Details
    Table 62. Alexion Pharmaceutical Inc. Business Overview
    Table 63. Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Product
    Table 64. Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 65. Alexion Pharmaceutical Inc. Recent Development
    Table 66. Grifols SA Company Details
    Table 67. Grifols SA Business Overview
    Table 68. Grifols SA Myasthenia Gravis Treatment Product
    Table 69. Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 70. Grifols SA Recent Development
    Table 71. Avadel Pharmaceuticals plc. Company Details
    Table 72. Avadel Pharmaceuticals plc. Business Overview
    Table 73. Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Product
    Table 74. Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 75. Avadel Pharmaceuticals plc. Recent Development
    Table 76. Novartis AG Company Details
    Table 77. Novartis AG Business Overview
    Table 78. Novartis AG Myasthenia Gravis Treatment Product
    Table 79. Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 80. Novartis AG Recent Development
    Table 81. Pfizer; Inc. Company Details
    Table 82. Pfizer; Inc. Business Overview
    Table 83. Pfizer; Inc. Myasthenia Gravis Treatment Product
    Table 84. Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 85. Pfizer; Inc. Recent Development
    Table 86. AbbVie Inc. Company Details
    Table 87. AbbVie Inc. Business Overview
    Table 88. AbbVie Inc. Myasthenia Gravis Treatment Product
    Table 89. AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 90. AbbVie Inc. Recent Development
    Table 91. F. Hoffmann-La Roche Ltd. Company Details
    Table 92. F. Hoffmann-La Roche Ltd. Business Overview
    Table 93. F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Product
    Table 94. F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 95. F. Hoffmann-La Roche Ltd. Recent Development
    Table 96. GlaxoSmithKline plc Company Details
    Table 97. GlaxoSmithKline plc Business Overview
    Table 98. GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 99. GlaxoSmithKline plc Recent Development
    Table 100. Bausch Health Companies Inc. Company Details
    Table 101. Bausch Health Companies Inc. Business Overview
    Table 102. Bausch Health Companies Inc. Myasthenia Gravis Treatment Product
    Table 103. Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 104. Bausch Health Companies Inc. Recent Development
    Table 105. Shire plc. Company Details
    Table 106. Shire plc. Business Overview
    Table 107. Shire plc. Myasthenia Gravis Treatment Product
    Table 108. Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 109. Shire plc. Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Myasthenia Gravis Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Medication Features
    Figure 3. Surgery Features
    Figure 4. Global Myasthenia Gravis Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Myasthenia Gravis Treatment Report Years Considered
    Figure 9. Global Myasthenia Gravis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Myasthenia Gravis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Myasthenia Gravis Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Myasthenia Gravis Treatment Market Share by Players in 2020
    Figure 14. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Myasthenia Gravis Treatment Revenue in 2020
    Figure 16. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 20. North America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 21. North America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 22. United States Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Myasthenia Gravis Treatment Market Share by Region (2016-2027)
    Figure 38. China Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Alexion Pharmaceutical Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 58. Grifols SA Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 59. Avadel Pharmaceuticals plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 60. Novartis AG Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 61. Pfizer; Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 62. AbbVie Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 65. Bausch Health Companies Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 66. Shire plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Myasthenia Gravis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Medication
    Surgery
Segment by Application
    Hospitals
    Clinics
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Alexion Pharmaceutical Inc.
    Grifols SA
    Avadel Pharmaceuticals plc.
    Novartis AG
    Pfizer; Inc.
    AbbVie Inc.
    F. Hoffmann-La Roche Ltd.
    GlaxoSmithKline plc
    Bausch Health Companies Inc.
    Novartis AG
Read More
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Treatment Market Perspective (2016-2027)
2.2 Myasthenia Gravis Treatment Growth Trends by Regions
2.2.1 Myasthenia Gravis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myasthenia Gravis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Myasthenia Gravis Treatment Industry Dynamic
2.3.1 Myasthenia Gravis Treatment Market Trends
2.3.2 Myasthenia Gravis Treatment Market Drivers
2.3.3 Myasthenia Gravis Treatment Market Challenges
2.3.4 Myasthenia Gravis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis Treatment Players by Revenue (2016-2021)
3.1.2 Global Myasthenia Gravis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Myasthenia Gravis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Treatment Revenue
3.4 Global Myasthenia Gravis Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Treatment Revenue in 2020
3.5 Myasthenia Gravis Treatment Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Treatment Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027)
5 Myasthenia Gravis Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Myasthenia Gravis Treatment Market Size (2016-2027)
6.2 North America Myasthenia Gravis Treatment Market Size by Type
6.2.1 North America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
6.2.2 North America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
6.2.3 North America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
6.3 North America Myasthenia Gravis Treatment Market Size by Application
6.3.1 North America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
6.3.2 North America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
6.3.3 North America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
6.4 North America Myasthenia Gravis Treatment Market Size by Country
6.4.1 North America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
6.4.2 North America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Myasthenia Gravis Treatment Market Size (2016-2027)
7.2 Europe Myasthenia Gravis Treatment Market Size by Type
7.2.1 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2027)
7.3 Europe Myasthenia Gravis Treatment Market Size by Application
7.3.1 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2027)
7.4 Europe Myasthenia Gravis Treatment Market Size by Country
7.4.1 Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type
8.2.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application
8.3.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region
8.4.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Treatment Market Size (2016-2027)
9.2 Latin America Myasthenia Gravis Treatment Market Size by Type
9.2.1 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
9.3 Latin America Myasthenia Gravis Treatment Market Size by Application
9.3.1 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
9.4 Latin America Myasthenia Gravis Treatment Market Size by Country
9.4.1 Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type
10.2.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application
10.3.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country
10.4.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceutical Inc.
11.1.1 Alexion Pharmaceutical Inc. Company Details
11.1.2 Alexion Pharmaceutical Inc. Business Overview
11.1.3 Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Introduction
11.1.4 Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.1.5 Alexion Pharmaceutical Inc. Recent Development
11.2 Grifols SA
11.2.1 Grifols SA Company Details
11.2.2 Grifols SA Business Overview
11.2.3 Grifols SA Myasthenia Gravis Treatment Introduction
11.2.4 Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.2.5 Grifols SA Recent Development
11.3 Avadel Pharmaceuticals plc.
11.3.1 Avadel Pharmaceuticals plc. Company Details
11.3.2 Avadel Pharmaceuticals plc. Business Overview
11.3.3 Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Introduction
11.3.4 Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.3.5 Avadel Pharmaceuticals plc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Myasthenia Gravis Treatment Introduction
11.4.4 Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer; Inc.
11.5.1 Pfizer; Inc. Company Details
11.5.2 Pfizer; Inc. Business Overview
11.5.3 Pfizer; Inc. Myasthenia Gravis Treatment Introduction
11.5.4 Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.5.5 Pfizer; Inc. Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Myasthenia Gravis Treatment Introduction
11.6.4 AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Details
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Myasthenia Gravis Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline plc Recent Development
11.9 Bausch Health Companies Inc.
11.9.1 Bausch Health Companies Inc. Company Details
11.9.2 Bausch Health Companies Inc. Business Overview
11.9.3 Bausch Health Companies Inc. Myasthenia Gravis Treatment Introduction
11.9.4 Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.9.5 Bausch Health Companies Inc. Recent Development
11.10 Shire plc.
11.10.1 Shire plc. Company Details
11.10.2 Shire plc. Business Overview
11.10.3 Shire plc. Myasthenia Gravis Treatment Introduction
11.10.4 Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.10.5 Shire plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Read More
List of Tables
    Table 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medication
    Table 3. Key Players of Surgery
    Table 4. Global Myasthenia Gravis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Myasthenia Gravis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Myasthenia Gravis Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Myasthenia Gravis Treatment Market Share by Regions (2016-2021)
    Table 8. Global Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
    Table 10. Myasthenia Gravis Treatment Market Trends
    Table 11. Myasthenia Gravis Treatment Market Drivers
    Table 12. Myasthenia Gravis Treatment Market Challenges
    Table 13. Myasthenia Gravis Treatment Market Restraints
    Table 14. Global Myasthenia Gravis Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Myasthenia Gravis Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020)
    Table 17. Ranking of Global Top Myasthenia Gravis Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Myasthenia Gravis Treatment Product Solution and Service
    Table 21. Date of Enter into Myasthenia Gravis Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Myasthenia Gravis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Alexion Pharmaceutical Inc. Company Details
    Table 62. Alexion Pharmaceutical Inc. Business Overview
    Table 63. Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Product
    Table 64. Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 65. Alexion Pharmaceutical Inc. Recent Development
    Table 66. Grifols SA Company Details
    Table 67. Grifols SA Business Overview
    Table 68. Grifols SA Myasthenia Gravis Treatment Product
    Table 69. Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 70. Grifols SA Recent Development
    Table 71. Avadel Pharmaceuticals plc. Company Details
    Table 72. Avadel Pharmaceuticals plc. Business Overview
    Table 73. Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Product
    Table 74. Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 75. Avadel Pharmaceuticals plc. Recent Development
    Table 76. Novartis AG Company Details
    Table 77. Novartis AG Business Overview
    Table 78. Novartis AG Myasthenia Gravis Treatment Product
    Table 79. Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 80. Novartis AG Recent Development
    Table 81. Pfizer; Inc. Company Details
    Table 82. Pfizer; Inc. Business Overview
    Table 83. Pfizer; Inc. Myasthenia Gravis Treatment Product
    Table 84. Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 85. Pfizer; Inc. Recent Development
    Table 86. AbbVie Inc. Company Details
    Table 87. AbbVie Inc. Business Overview
    Table 88. AbbVie Inc. Myasthenia Gravis Treatment Product
    Table 89. AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 90. AbbVie Inc. Recent Development
    Table 91. F. Hoffmann-La Roche Ltd. Company Details
    Table 92. F. Hoffmann-La Roche Ltd. Business Overview
    Table 93. F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Product
    Table 94. F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 95. F. Hoffmann-La Roche Ltd. Recent Development
    Table 96. GlaxoSmithKline plc Company Details
    Table 97. GlaxoSmithKline plc Business Overview
    Table 98. GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 99. GlaxoSmithKline plc Recent Development
    Table 100. Bausch Health Companies Inc. Company Details
    Table 101. Bausch Health Companies Inc. Business Overview
    Table 102. Bausch Health Companies Inc. Myasthenia Gravis Treatment Product
    Table 103. Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 104. Bausch Health Companies Inc. Recent Development
    Table 105. Shire plc. Company Details
    Table 106. Shire plc. Business Overview
    Table 107. Shire plc. Myasthenia Gravis Treatment Product
    Table 108. Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
    Table 109. Shire plc. Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Myasthenia Gravis Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Medication Features
    Figure 3. Surgery Features
    Figure 4. Global Myasthenia Gravis Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Myasthenia Gravis Treatment Report Years Considered
    Figure 9. Global Myasthenia Gravis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Myasthenia Gravis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Myasthenia Gravis Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Myasthenia Gravis Treatment Market Share by Players in 2020
    Figure 14. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Myasthenia Gravis Treatment Revenue in 2020
    Figure 16. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 20. North America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 21. North America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 22. United States Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Myasthenia Gravis Treatment Market Share by Region (2016-2027)
    Figure 38. China Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Myasthenia Gravis Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Myasthenia Gravis Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Myasthenia Gravis Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Alexion Pharmaceutical Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 58. Grifols SA Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 59. Avadel Pharmaceuticals plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 60. Novartis AG Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 61. Pfizer; Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 62. AbbVie Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 65. Bausch Health Companies Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 66. Shire plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Anosmia Market Size Status and Forecast 2021 2027
Global Anosmia Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-27U4147
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0